chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Third dose: eyes feel like they're going to die from all the pins and needles; Third dose: feeling like millions of pins and needles coming out of her body- her eyes, nose, tongue, she can feel it in her chest and in her colon; Third dose: feeling like millions of pins and needles coming out of her body- her eyes, nose, tongue, she can feel it in her chest and in her colon; Third Dose: 3 nights where she didn't sleep; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202200348380 (pfizer).  A female patient received bnt162b2 (BNT162B2), administration date 23Sep2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for Covid-19 immunization, reaction(s): "no reaction"; Bnt162b2 (Dose: 2), for Covid-19 immunization, reaction(s): "Second Dose: on the very end of it she had a slight reaction of like pins and needles but then it went away and she got rid of that". The following information was reported: EYE PARAESTHESIA (medically significant) with onset 25Sep2021, outcome "unknown", described as "Third dose: eyes feel like they're going to die from all the pins and needles"; PARAESTHESIA ORAL (medically significant), PARAESTHESIA (medically significant) all with onset 25Sep2021, outcome "unknown" and all described as "Third dose: feeling like millions of pins and needles coming out of her body- her eyes, nose, tongue, she can feel it in her chest and in her colon"; INSOMNIA (non-serious) with onset 25Sep2021, outcome "unknown", described as "Third Dose: 3 nights where she didn't sleep". After 2 days the caller started to feel like there are a million pins and needles internal, in her stomach and her body and she was in terrible shape. Usually if the patient has a reaction to something she gets a steroid injection. The patient generally doesn't like to take the steroid injections. Therapeutic measures were taken with steroid injection as a result of eye paraesthesia, paraesthesia oral, paraesthesia, insomnia.  Clinical information: The patient got a steroid injection yesterday against her doctor's better judgement. The doctor didn't want to give it to her because it would work so hard against something. But the patient has got to have some relief because she had 3 nights where she didn't sleep. The patient lays down and it was like a million pins and needles coming out her head, it was so painful and powerful she would rub her head to make sure the pins weren't actually there and its horrible. This has happened really severe.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Dizziness, Headaches, Migraine, body aches,  joint pain, injection site pain, nauseous, fast heartbeat, body itchiness, and heartburn.
Injection site swelling; Injection site pain; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE SWELLING (Injection site swelling) and VACCINATION SITE PAIN (Injection site pain) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure, Neuropathy and Bacterial infection (Patient is taking antibiotic for small intestine bacterial overgrowth).    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Injection site swelling) and VACCINATION SITE PAIN (Injection site pain). At the time of the report, VACCINATION SITE SWELLING (Injection site swelling) and VACCINATION SITE PAIN (Injection site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication include medicine for blood pressure and neuropathy. Also an antibiotic for SIBO. No treatment information was provided.
few days after vaccine pt went into florid Congestive Heart failure and has low output cardiomyopathy since then with Ejection fraction = 25%.  Pt currently has AICD implanted
This spontaneous report as received from a pharmacist refers to a 50 year old female patient. On an unknown date the patient was vaccinated with ZOSTAVAX. Concomitant medication was not provided. On an unknown date the patient experienced redness around the injection site, not long after the shot. There was no rash. The redness around the injection site improved after stopping therapy. Patient present status: about a week after it started. The relatedness for the adverse event was not reported for ZOSTAVAX. Additional information is not expected.
Patient experienced clogged ears, drowsiness, loss of vision, ringing in ears, sweating, weakness, and shakes  approximately 2 minutes after receiving her first Moderna Covid 19 vaccine. Patient was promptly given an ice pack to apply to neck and energy drink. Resolution occurs approximately 10 minutes after vaccination.
Received vaccine 2/1/8 but developed shingles 7/8/9 anyway.
Pt with recurrent, focal, urticarial plaques localized only to right upper arm (from shoulder to elbow) occurring a few weeks after receiving anthrax vaccine #6 and recurring every 2-5 days and lasting for hours persistent X 5 months since vaccine to right shoulder in March 2000. Still has facial urticaria episodes to right arm.
This literature market report was received from an author. Abstract: Studies assessing the economic burden of a mumps outbreak in a highly vaccinated population are limited. A mumps investigation was conducted in an affected village with a highly vaccinated population. To understand the epidemiology, standardized mumps case definition and active surveillance were used to identify mumps cases. In addition, an economic assessment of a combined outbreak investigation and third dose MMR vaccine intervention was performed; estimated by retrospectively evaluating public health response-related activities including use of a third dose of MMR vaccine. From 24-SEP-2009 through 15-JUN-2010, 790 mumps cases were reported-64% were male and highest attack rate was among 11-17 year age group (99.1 cases per 1000 individuals). Of the 658 cases with known vaccination history, 83.6% had documentation of 2 doses of mumps containing vaccine. No deaths were reported. The 2 major exposure settings were schools (71.8%) and households (22.5%). Mumps cases were classified according to the 2008 mumps definition of the Epidemiologists. A clinical case was defined as an illness with acute onset of the parotitis, lasting at least 2 days, and without apparent cause. Clinically compatible illness was defined as that which may present as aseptic meningitis, encephalitis, hearing loss, orchitis, oophoritis, parotitis, or other salivary gland swelling, mastitis or pancreatitis. Laboratory confirmation included isolation of mumps virus from clinical specimen, or detection of mumps nucleic acid, or detection of mumps IgM antibody, or demonstration of a 4-fold increase in mumps IgG antibody titer. Mumps cases were then classified epidemiologically. A probable case was defined as that which meets the clinical case definition without laboratory confirmation and was epidemiologically linked to a clinically compatible case. A confirmed case was defined as a case that met the clinical case definition or had clinically compatible illness, and was either laboratory confirmed or was epidemiologically linked to a confirmed case. This report refers to the 27 case-patients with documented 2 doses of MMR (manufacturer unknown) vaccine, 27 (15%) were found to be mumps IgM antibody positive and on an unknown date the patients developed parotitis. The outcome of event was unknown. The reporter considered events to be related to MMR (manufacturer unknown). This is one of the several reports with literature linked. Additional information has been requested.
Passed out at school. Fell off of desk chair and bump his head on desk next to him.
At first fever, chills, weakness, tired, headache. That mostly went away, 3 days after the shot my heart was racing constantly, has not stopped since.  Restless leg syndrome when I sleep.   When I sit in a chair my feet and hands immediately go to sleep( tingle and get cold). My feet tingle when I stand now. I've never had circulation problems ever in my life. I can now feel my heart working harder to pump blood through my body. 01/10/22 I had my first sharp chest pain (on my right side) it felt like I was being stabbed, and sharp pains through my spinal chord. Today 01/11/22 my heart feels minor pain maybe inflammation.
A report had been received from a Health Professional (Medical Assistant) via medical representative concerning a 2 year old, patient of unknown gender. No information regarding medical history, concomitant disease or concomitant medication was provided. Medical Assistant reported that the patient came into their family practice last year and was tested for flu. Patient had gotten FLUMIST QUADRIVALENT (intranasal) two weeks earlier and gave flu to the family. The FLUMIST QUADRIVALENT was given in another office. Action taken with FLUMIST QUADRIVALENT and outcome of the event was unknown. The report was considered to be non-serious by the reporter.
Felt uneasy; Not able to eat anything; Fever of 103F; Vomiting; Bad headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt uneasy), FEEDING DISORDER (Not able to eat anything), PYREXIA (Fever of 103F), VOMITING (Vomiting) and HEADACHE (Bad headache) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033B21A and 002B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-May-2021, the patient experienced FEELING ABNORMAL (Felt uneasy), FEEDING DISORDER (Not able to eat anything), PYREXIA (Fever of 103F), VOMITING (Vomiting) and HEADACHE (Bad headache). The patient was treated with PARACETAMOL (TYLENOL) on 13-May-2021 at a dose of 1 dosage form. At the time of the report, FEELING ABNORMAL (Felt uneasy), FEEDING DISORDER (Not able to eat anything), VOMITING (Vomiting) and HEADACHE (Bad headache) outcome was unknown and PYREXIA (Fever of 103F) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-May-2021, Body temperature: 103 (High) high.         As reported stated patient took Tylenol the morning of report (13-May-2021) with no relief. On 13-May-2021, his fever went up, then down, then up again.  Concomitant medications were not reported.   This case was linked to MOD-2021-128346 (Patient Link).
COVID-19 Symptoms returned No better; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (COVID-19 Symptoms returned No better) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. unknown) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 prophylaxis: Comirnaty. Past adverse reactions to the above products included Tachycardia with Comirnaty.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19 Symptoms returned No better). At the time of the report, COVID-19 (COVID-19 Symptoms returned No better) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: tachycardia.     The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment medications were not reported.  On an unknown date, the patient, with no cardiac history, developed tachycardia several weeks after Pfizer COVID-19 vaccine. The patient seemed better until then and after having Moderna booster, the COVID-19 symptoms returned and was not better.   On an unknown date, the patient saw a cardiologist and the tachycardia was documented on electrocardiogram (EKG) and halter monitors.
82 year old vaccinated male with dementia and COPD was admitted for hypotension and elevated troponin. He also tested (+) for Covid-19 infection. He received Remdesivir therapy. Cardiology determined he did not require further investigation after echo showed normal LVEF. CT showed signs of PE. BLE venous US (-) for thrombus. He has been on anticoagulation here and was discharged home on Xarelto.
Rapid heart rate and lightheadedness occurred 25 minutes after the vaccine. An ambulance was called and the symptoms subsided after about five minutes.
Severe arm pain tingling in fingers. 5 days later severe pain unable to lift arm to get dressed. Little effect with pain meds.
Two weeks after each shot I developed a rash on my forearm that looked like blood pooling under the skin.  Approximately two weeks later the rash faded.  One was one my left and one was on my right arm.  This week, three weeks after the start of the 2nd rash, I developed two more spots.
The day after the injection I had periods where the injection sight was warm to the touch (noticeably different temperature than the rest of my skin on my upper arm). By midmorning my left upper arm was very tender and extremely painful to the touch, even my shirt touching my skin hurt. By mid afternoon I was very fatigued and had to leave work and took a three hour nap. By the end of the evening the pain was resolved.
No Adverse Event Occurred, however the details of a double vaccination of a child are as follows: At 2:15PM child, DOB 2/8/2004, was double vaccinated with the Pfizer COVID-19 vaccine. The child sat at the end of one of the COVID-19 vaccine stations. The RN vaccinated the child after the child was screened. The child was instructed to walk to the Nurse scanning and collecting the paperwork. The child who speaks Akateko and very little Spanish went to a second vaccine station where a second nurse vaccinated the child a second time unknowingly. The stations are positioned laterally from each other. The vaccination station was two spots down from where the child sat the first time. The second nurse did not realize she vaccinated a child who had already been vaccinated until she went to document her vaccination on the back of the screening sheet. The Nurse then saw another Nurse had already signed off on giving the vaccination. The screening questions are on the front and the vaccinator signature and location of vaccine is on the back. The  Nurse notified the Nursing Supervisor of the medication error. Nursing Supervisor immediately notified the provider (Nurse Practitioner) on the vaccine site of the incident. The child was brought to the observation unit of the vaccine site for close monitoring. Simultaneously, RN  called Deputy Chief Medical Officer and notified him of the incident. The DCMO came to the vaccine site immediately and called the Center for Disease Control onsite lead for recommendations. The DMCO reported back to the vaccine clinic provider that we would monitor the child for 30-45 minutes and CDC stated the child could go back to his regular dorm and if the child feels any symptoms, then he is to go see Medical. As soon as we knew of any recommendations, we used Masterword Interpreter Services to schedule a Akateko translator over the phone at the vaccine site. With the interpreter service, the provider explained to the child what exactly happened and answered questions for the child. The child was brought to observation unit for close monitoring as a precaution and will be returned to general population if the child is still feeling fine. During the initial hour of observation at the vaccine site, the child reported no symptoms or signs of an adverse reaction.
Pt stated her eyes and lips started to swell on the way home. She went to a facility for treatment. They would NOT give her a steroid injection. They prescribed, Pepcid, Atarax & Prednisone which she picked up the next day
Received 2 doses of DTaP/IPV and MMRV; monitored for 15 minutes and no adverse reactions.
Patient reports starting 8/26/23 that arm  was swollen in a contained area around injection site exhibiting redness and itching. Patient reports using hydrocortisone to reduce itching and was advised to take benadryl and use ice pack along with OTC tylenol or ibuprofen for discomfort.
About 40 minutes post vaccination patient's face became red and developed a rash.  Benedryl given and she was released home 30 minutes later.
Light headedness and dizziness; Achy; Tired; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headedness and dizziness), PAIN (Achy) and FATIGUE (Tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 015M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced PAIN (Achy) and FATIGUE (Tired). On 15-Mar-2021, the patient experienced DIZZINESS (Light headedness and dizziness). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, DIZZINESS (Light headedness and dizziness), PAIN (Achy) and FATIGUE (Tired) outcome was unknown.            No relevant concomitant medications were reported.
Where T-dap was given - 19x16 cm area of erythema with mild swelling, nontender, no discharge, not indurated, mild increased warmth.
pt recv vax 29AUG96 & 31AUG96 pt exp a fever w/erythema & pain @ inj site;As of 18SEP96 pt was getting better;
Tested positive 8/16 and arrived with increasing SOB, dx with COVID pna. On 3-4 L O2 at baseline. Treated with O2, lovenox, steroids, zinc, vit-c. Stable on 6L O2 and discharged home on increased O2.
COVID infection following COVID vaccine series "He has been fully vaccinated against COVID but has not yet had a booster." 12/23 pt admit to ED cc: N/V and headache dx: COVID 19 infection LOS: 1 day 12/23 COVID swab, result: detected 08/03 pt cc: nausea, vomiting, headache exposure: unknown clinically resolved
Vaccine administered pt waited 15 mins, no issues. Pt called at 1104 A stating had rash-hive like on inner things - itched, at 1118 called again but hung up-provider returned call x 2-left message at 1147 A called - she couldn't come in until after 1pm. She took BENADRYL; Pt assessed at 120 pm-legs red no rash. *Recommeded sooner evaluation*.
Pt recvd 2nd dose of vax & exp itching on upper body & had small rash; scratching causes vax to break out;
Shot 1- shaky, weak, increased heart rate, mild swelling of mouth tongue and throat - resolved in a day  Shot 2 a shaky, weak, increased heart rate and blood pressure, moderate swelling of face, tongue, throat, intermittent dizziness and Left eye blurriest, left facial decreased sensation and pain from mouth to ear, pain behind Left eye - symptoms wax and wane throughout the day
I think it was February 20th, 2023. I developed a sore throat, cough, and a low grade fever. I did a COVID19 test on the 21st and one on the 22nd, the first one was negative, but the second one was positive. I called my doctor and he prescribed PAXLOVID, which I started on the 23rd and took through the 27th. By Tuesday the symptoms had subsided, but on March 3rd I developed a racking Bronchitis cough. By the 6th I had to go to urgent care and she prescribed a MEDROL pack which I took for 5 days. It relieved the symptoms but by the 13th the cough had come back. I visited my doctor again and he prescribed a powder inhaler, TRELEGY. I am still taking it and it has helped but I still have a little bit of a cough. I've also been taking a MOTRIN cough syrup.
Tonic-clonic seizure started about 7 minutes after receiving dose. Lasted about 30 seconds. Arms and legs jerking. After about 30 seconds patient gained conciseness again.
symptoms: fever 103F, fatigue, headache, nausea, soreness at injection site - treatment: rest, fluids, acetaminophen, ondansetron
within 24 hours injection site began swelling, became 'hard' and 'warm' to the touch, continue to enlarge over the next few days.  4/13/21 saw primary care doctor who said i have an infection. prescribed antibiotic (cephalexin 500 mg) (3 times daily for 7 days) AND mupirocin ointment USP 2% (3 times daily for 7 days).  no known allergies.
elevate her heart rate; This is a spontaneous report from a Pfizer Sponsored Program from contactable female consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 11Mar2021 as a single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient had her first dose yesterday, on 11Mar2021, and her heart got elevated on an unknown date in Mar2021. She is asking, will the second dose of the COVID vaccine elevate her heart rate more. The outcome of the event was unknown.   The lot number for the vaccine, BNT162B2, was not provided and has been requested.
Within 24 hours of vaccine, the pt developed a fever of 99.8. On 10/28/99 the pt experienced ear pressure, persisting fever and malaise through 11/2/99. On 11/3/99, the pt experienced a runny nose, headache, abdominal pain and diarrhea. The following day, the pt developed a fever of 102, hallucinated and experienced perisistent diarrhea. On 11/8/99, the pt was taken to and urgent care center where she was treated with Biaxin, and Tylenol. On 11/15/99, the pt experienced congestion and other symptoms persistning. Additional information has been requested. Follow up states the patient experienced hip and shoulder pain as well as a swollen left hand.
Information has been received from a consumer concerning her 14 year old daughter with no pertinent medical history and no drug reactions or allergies who on an unspecified date, was vaccinated IM with 0.5 ml first dose of GARDASIL (Lot# not reported). There was no concomitant medication. It was reported that the consumer's daughter on 23-AUG-2010, experienced pain and swelling after being administered GARDASIL. The consumer did not know if it was from a flu vaccination or GARDASIL and she was trying to figure out what caused her daughter's reaction. Lab diagnostics studies were not performed. At the time of the report, the consumer's daughter had not recovered. She did not seek medical attention. Additional information has been requested.
Shingles on left-side of chest and along dermatome to left side of spine. No treatment other than topical Benadryl for itching and Tylenol for pain as needed. Patient outside of 72-hour window for antiviral treatment. Mom stated rash has been present for one week.